Neuro-cognitive impairment and associated symptoms in HIV-positive patients who switch from efavirenz-based cART to Emtricitabine/rilpivirine/tenofovir-disoproxil-fumarate
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 02 Jan 2017 New trial record